Side-by-side comparison
ABBV vs VRTX — Side-by-side comparison
ABBV screens cheaper on EV/FCF, VRTX has the higher ROIC, VRTX has grown revenue faster over five years, and ABBV has the cleaner balance sheet by net debt / EBITDA.
ABBV
AbbVie Inc.
Price
$215.70
Market cap
$346.8B
Day %
N/A
VRTX
VERTEX PHARMACEUTICALS INC / MA
Price
N/A
Market cap
N/A
Day %
N/A
ABBV implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
22.8x
FCF yield
5.1%
5Y rev CAGR
6.0%
VRTX implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
14.1%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for ABBV.
Grade C
51
/ 100
Quality Scorecard
Build-time composite score for VRTX.
Grade D
38
/ 100